Amarantus Bioscience Holdings, Inc. — Regulation A 1-A
Amarantus Bioscience Holdings, Inc. of New York, NY filed a Regulation A 1-A with the SEC on 2020-01-09. Aggregate offering: $5.0M (Tier 1). Industry: Other.
Offering
- Filed: 2020-01-09
- Form: 1-A
- Accession: 0001213900-20-000662
- Tier: Tier 1
- Total aggregate offering: $5.0M
- Issuer portion: $5.0M
- Price per security: $0.1000
- Securities offered: Equity (common or preferred stock)
- Audit status: Unaudited
- Jurisdictions: 1 states/territories
Issuer
- CIK: 0001424812
- Organized in: NV
- Incorporated: 2008
- Address: 45 Wall Street, New York, NY, 10005
- Phone: 650-862-5391
- Employees: 4 full-time, 1 part-time
Financial snapshot (as filed)
- Total assets: $5.5M
- Cash & equivalents: $783K
- Total liabilities: $35.5M
- Stockholder equity: $-30.0M
- Net income: $-824K
People (1)
| Name | Role | Location |
|---|
| William Eilers, Eilers Law Gro | Signer | SAN CLEMENTE, CA |
Other Reg A filings by this issuer (2)
More